ROBINS CHAD M bought ADPT
March 6, 2026 · Form 4 insider transaction
ROBINS CHAD M bought 709,220 shares of Adaptive Biotechnologies Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
709,220
Price
$0.00
Total value
N/A
InsiderROBINS CHAD M
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 6, 2026
Filing dateMarch 6, 2026
Shares owned after2,771,280
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance share unit represents a contingent right to receive one share of the issuer's common stock. The performance share units were granted on March 6, 2023, with respect to the three-year period ending on March 6, 2026. The issuer certified the achievement of the performance goals on March 6, 2026. The performance share units vested on March 6, 2026.